https://www.selleckchem.com/GSK-3.html
ion with the miR-32 inhibitor (p less then 0.05), and significantly decreased after addition of the PTEN inhibitor SF1670, while the expressions of anti-apoptotic proteins Bcl-2 and survivin were opposite to those of Bak and caspase-9. CONCLUSIONS MiR-32 targeting PTEN will have certain effects on the proliferation and apoptosis of myeloma cells.OBJECTIVE Bone marrow mesenchymal stem cells (BMSCs) have the ability to differentiate into several cell lines and are critical for skeletal microenvironment and bone development. MiR-1301 is involved in m
Beğen
Yorum Yap
Paylaş
